Last reviewed · How we verify
Topical Coal tar — Competitive Intelligence Brief
marketed
Keratolytic and anti-inflammatory agent
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Topical Coal tar (Topical Coal tar) — Post Graduate Institute of Medical Education and Research, Chandigarh. Coal tar works by reducing skin cell proliferation, decreasing inflammation, and providing antimicrobial and antipruritic effects on the skin surface.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Topical Coal tar TARGET | Topical Coal tar | Post Graduate Institute of Medical Education and Research, Chandigarh | marketed | Keratolytic and anti-inflammatory agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Keratolytic and anti-inflammatory agent class)
- Post Graduate Institute of Medical Education and Research, Chandigarh · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Topical Coal tar CI watch — RSS
- Topical Coal tar CI watch — Atom
- Topical Coal tar CI watch — JSON
- Topical Coal tar alone — RSS
- Whole Keratolytic and anti-inflammatory agent class — RSS
Cite this brief
Drug Landscape (2026). Topical Coal tar — Competitive Intelligence Brief. https://druglandscape.com/ci/topical-coal-tar. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing